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Simultaneous presentation of
multifocal choroiditis and acute
zonal occult outer retinopathy in
one eye
CASE
A 20-year-old healthy female patient with moderate myopia
who had a bipolar disorder was referred to us by her primary
ophthalmologist because of a 3-year history of photopsia and
painless visual field loss in her right eye that had accelerated in
the past 7 months. She had not been taking any medications
except oral contraceptives.
The patient had been referred to a neuro-ophthalmologist
2 months before our visit.
Clinical examination of the right eye revealed a relative
afferent pupillary defect and a dense temporal field defect that
appeared to respect the vertical meridian, with some involve-
ment of the fovea (figure 1). The retinal pigment epithelium
(RPE) changes in the temporal fundus (figure 1) were interpreted
as a demarcation line from an antecedent retinal detachment. At
that time, the patient was found as having a right optic
neuropathy. Subsequently, a magnetic resonance imaging of the
brain was performed, which yielded an unremarkable result. The
finding of an extensive inflammatory, infectious andhaematologic
laboratory workup was negative.
Upon examination in our office, the patient’s best corrected
visual acuity was 20/30 in the right eye and 20/20 in the left eye.
Intraocular pressure was 16 mm Hg bilaterally. A mild cellular
reaction was seen in the anterior vitreous of the right eye. The
fundus of the right eye revealed peripapillary atrophy and a focal
area of hyperpigmentation located inferotemporally to the optic
nerve. There were multiple round greyish yellow punched-out
lesions with variable pigmentation arranged in a curvilinear
streak in the temporal periphery of the retina (figure 1). The
fundus of the left eye was normal except for a small temporal
myopic conus and a subtle non-specific RPE disturbance just
inferior to fixation.
Fundus autofluorescence (AF) photography of the right eye
demonstrated hypoautofluorescence surrounding the optic nerve
that was more intense temporally due to presumed RPE damage
(figure 1). The temporal curvilinear streak appeared hypoauto-
fluorescent secondary to RPE alterations. Fluorescein angiog-
raphy (FA) of the right eye demonstrated staining of the
temporal chorioretinal spots with some subtle window defects
surrounding the optic nerve (figure 1).
QUESTIONS
1. What is the differential diagnosis based upon the biomicro-
scopic findings, the visual field, the AF photography and the
FA?
2. What other test(s) would help clarify the diagnosis?
Figure 1 (A) Composite photograph of the right fundus showing both punched-out chorioretinal lesions in the temporal periphery forming a curvilinear
streak and peripapillary pigmentary alterations. (B) AF photograph of the right eye revealing RPE abnormalities surrounding the optic nerve. (C) The
visual field of the right eye demonstrates a moderately dense temporal scotoma that respects the vertical meridian except in the parafoveal area where
the scotoma extends slightly inferior to fixation. (D/E) FA of the right eye demonstrating staining of the temporal chorioretinal spots with some very
subtle window defects surrounding the optic nerve.
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3. How should this patient be treated?
See page 297 for answers
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ANSWERS
From questions on page 288
1. What is the differential diagnosis based upon the biomicro-
scopic findings, the visual field, the autofluorescence
photography and the fluorescein angiography (FA)?
This patient exhibited two of the signs in the clinical triad
of the presumed ocular histoplasmosis syndrome (POHS),
which includes peripapillary atrophy, disseminated
punched-out atrophic spots and choroidal neovascularisa-
tion. Fountain and Schlaegel1 noted that peripheral curvi-
linear streaks composed of chorioretinal scars can be
a fourth sign of POHS (figure 1). The convexity of these
curvilinear streaks is typically orientated towards the optic
nerve unlike the pigmented demarcation line in rhegmatog-
enous retinal detachment that is usually oriented towards
the ora serrata. Thus, many of the ocular findings of POHS
are similar, if not identical, to multifocal choroiditis with
panuveitis (MCP). The presence of intraocular inflammation
in MCP is the critical feature distinguishing it from POHS,2 3
but this finding may be episodic.
Enlarged blind spots or visual field defects correlating to the
fundus lesions are seen in MCP. This patient’s large right
temporal field defect is out of proportion to her funduscopic
findings. Gass first described an idiopathic condition where
patients, usually young women, developed photopsia and
acute progressive visual field loss in one or both eyes due to
damage of broad zones of the outer retina. He termed this
pattern acute zonal occult outer retinopathy (AZOOR).4 The
hallmark of this disease is that the visual field defect is
unexplained by the fundus findings. Given our patient’s sex,
age, clinical presentation and relatively normal appearing
fundus, the diagnosis is most likely MCP and AZOOR.4
2. What other test(s) would help clarify the diagnosis?
Electrophysiological testing can be helpful for the early
diagnosis of AZOOR. The electroretinogram (ERG) typi-
cally shows a cone system with 30 Hz flicker delay,
indicative of photoreceptor damage. A decreased light rise,
indicative of retinal pigment epithelium (RPE) compromise,
is seen on electro-oculogram.5 The severity of ERG
abnormalities is variable and generally correlate to the
degree of visual field loss,4 but normal ERG findings have
also been reported.
Our patient underwent Spectralis HRA+OCT (Heidel-
berg Engineering, Heidelberg, Germany), which demon-
strated defects in the junction between the inner (IS) and
outer segments (OS) of the photoreceptors (the IS/OS
boundary) that encroached close to the fovea and corre-
sponded precisely with the visual field defects (figure 2).7
Given this clear evidence of photoreceptor damage, we did
not feel that an ERG was necessary to make the diagnosis in
our patient.
3. How should this patient be treated?
In limited studies, diseases of the AZOOR complex have
responded to immunosuppressive drugs. However, since this
treatment can take up to 8 weeks to be effective,we elected to
treat her initially with a subtenon injection of triamcinolone
acetonide in the affected eye in an attempt to more rapidly
prevent further vision loss.4 7 8 We chose not to give oral
corticosteroids to avoid systemic andneuropsychiatric adverse
effects, especially given her unilateral presentation and the
history of bipolar disorder. She was referred to a rheumato-
logist who initiated mycophenolate mofetil therapy.
DISCUSSION
This case demonstrates the importance of considering retinal
disease in the differential diagnosis of acute visual field loss with
minimal funduscopic changes, particularly when associated
with symptoms of photopsia. A recent report of a 17-month
delay in the diagnosis of AZOOR demonstrates the lack of
awareness of AZOOR in the current medical community.9
AZOOR was first described by Gass, who subdivided it into
two groups:10 11 AZOOR type 1 (occult) with primary retinal
receptor involvement and no funduscopic or FA changes corre-
sponding to the visual field loss and AZOOR type 2 (overt) with
combined photoreceptor and RPE involvement showing more
pronounced fundus and FA changes. Our patient fits more closely
in the first category currently. In their long-term follow-up study,
Gass et al reported that at the onset of AZOOR, the clinical
examination result was either normal or revealed changes unre-
lated toAZOOR in 91%of the affected eyes.On final examination
(median follow-up of 96 months), only 52% had normal fundi.4
The fundus picture of the late stages of AZOORmay mimic that
of either typical or segmental forms of retinitis pigmentosa.
AZOOR belongs to the AZOOR complex, which also includes
multiple evanescent white dot syndrome and MCP. Common to
all of these entities are a female predominance, photopsia,
a blind spot enlargement and ERG abnormalities. Gass11 12
proposed that AZOOR may be pathologically and aetiologically
related to multiple evanescent white dot syndrome, acute idio-
pathic blind spot enlargement syndrome, acute macular neuro-
retinopathy and MCP. Neither the trigger mechanism nor the
pathogenesis is known for any of these diseases. A higher
prevalence of autoimmune disease in patients with AZOOR has
been reported, but this does not necessarily indicate an
Figure 2 Spectral domain OCT demonstrating photoreceptor loss beginning just nasal to the foveal pit and extending to the optic nerve. The loss of
photoreceptors is indicated by the absence of the IS/OS boundary (arrow) representing the junction between the IS and OS of the photoreceptors.6 In
our patient, the IS/OS defects correlate precisely with the visual field abnormalities. Despite the loss of overlying photoreceptors, the RPE (arrow) in the
affected areas appears normal.
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autoimmune basis for the loss of vision. Our patient’s serologic
tests and inflammatory markers were negative, and she did not
exhibit other features suggestive of a connective tissue or an
autoimmune disease. Immunological reactions to previous viral
infections coupled with a genetic predisposition seem to be
a common denominator.
Transitions between the individual diseases have been
described.12 13 To our knowledge, there have been no other cases
reporting the simultaneous presentation of MCP and AZOOR in
the same eye.
To differentiate AZOOR from retrobulbar neuritis and other
lesions involving the posterior visual pathways, an ERG should
be obtained.4 Jacobson et al14 reported the electrophysiological
findings in 24 patients with diagnoses of the AZOOR complex.
Their results were in agreement with previous reports
suggesting that patients with AZOOR showed a pattern of
visual dysfunction that originated in the photoreceptor level.
Francis et al5 reported on 28 AZOOR patients and found an
electrophysiological pattern consistent with dysfunction both at
the photoreceptor/RPE complex and at the inner retinal levels,
namely, a delayed 30 Hz flicker ERG and a reduction in the
electro-oculogram light rise. These electrophysiological findings
may be helpful not only to establish the correct diagnosis but
also to monitor progression of disease or results of treatment.
In contrast to electrophysiological testing, high-resolution
spectral domain optical coherence tomography (OCT) can
directly and unequivocally reveal photoreceptor damage (loss of
IS/OS boundary), which correlate to the blind spot enlargement
and other visual field defects. Recently, we demonstrated this
correlation and also reported restoration of the IS/OS boundary
in some AZOOR complex patients with improvement in visual
field. Permanent loss of the IS/OS boundary was seen in patients
with persistent large visual field defects.6 The IS/OS boundary
defects in our patient coincided precisely with her visual field
changes, supporting that the aetiology of her visual defect was
retinal as opposed to neurological (figure 2B).
In limited studies, AZOOR and MCP have responded to
immunosuppressive drugs in addition to local or oral cortico-
steroid therapy.6 15 Both electrophysiological and spectral
domain OCT testings are helpful to objectively plot the course
of disease. However, whether immunosuppression can mean-
ingfully alter the natural course of disease needs further study.
Final diagnosis
This is a case of multifocal choroiditis and AZOOR presenting
simultaneously in the same eye.
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